Resource · Compliance · Malaysia

Advertising Guidelines for
Healthcare Facilities & Services.

What they cover, how they differ from treatment-level rules, and where they're published.

Last updated: August 2026

Quick answer: This is a plain-English summary of Malaysia's advertising guidelines for healthcare facilities and services — how the facility itself (premises, registration, location, services) is advertised, separate from treatment rules. Underlying law: Private Healthcare Facilities and Services Act 1998 (PHFSA), with MoH's Medicine Advertisements Board publishing facility guidance and issuing the KKLIU approval number that a Malaysian healthcare advertisement must display where the Medicines (Advertisement and Sale) Act 1956 applies.

Facility rules vs treatment rules — the distinction that matters

Malaysian healthcare advertising compliance operates on two separate layers, and this query sits on the layer most clinics never think about. Treatment-level rules — the KKM/MOH aesthetic framework, Malaysian Medical Council guidance, Malaysian Dental Council guidance — restrict claims about a specific procedure: guarantees, before/after photos, pricing, testimonials. Facility-level rules under the Private Healthcare Facilities and Services Act 1998 (Act 586, PHFSA) govern something different — how the premises itself is represented, independent of any treatment claim. A clinic can get its treatment-level advertising perfect and still fall foul of facility-level rules by, for example, presenting an unregistered premises as a licensed medical facility, or promoting the premises itself in a manner the Act restricts.

Who publishes the specific guidance

On top of the Act itself, the Ministry of Health's Medicine Advertisements Board (Lembaga Iklan Ubat) — the same body that approves medicine advertisements under the Medicines (Advertisement & Sale) Act 1956 — has published specific advertising guidelines for healthcare facilities and services, most recently as a dedicated MAB guideline document (ref. MAB 3.2023) hosted on the Ministry's Pharmaceutical Services Programme site. We were unable to independently verify the guideline's exact clause text this session — the hosting server didn't respond to a direct fetch — so we're not quoting specific provisions from it here; this page describes the framework it sits within rather than its clause-level content, and we'll update this page once we can verify the document directly.

KKLIU: the approval number your ad has to carry

KKLIU is the approval serial number issued by the Ministry of Health's Medicine Advertisements Board (Lembaga Iklan Ubat) under the Medicines (Advertisement and Sale) Act 1956. Where an advertisement falls inside the Act, it may not be published until the Board has approved it, and the approved advertisement must display the KKLIU number and its expiry. The Ministry's Pharmaceutical Services Programme publishes the scope, the application route and the format of the number itself.

Who needs one

The requirement attaches to the advertisement, not to the clinic. An advertisement that names a medicine, makes a medicinal claim, or offers a service for the purpose of treating or preventing a named condition falls inside the Act and needs Board approval. Ordinary practice advertising that stays on facts — registration, location, hours, practitioner qualifications, the consultation itself — generally does not. The line is the claim, not the channel, so the same copy needs the same assessment whether it runs on Meta, Google, TikTok or Xiaohongshu.

What an application actually involves, and how long it takes

Applications go through the Medicine Advertisements Board via the Ministry's advertisement-approval route, with the finished creative, the claims being made and the supporting evidence submitted together rather than the concept alone. Approvals are issued per advertisement and per version and carry an expiry date, so a re-cut, a translated variant or a materially changed claim is a fresh submission rather than a reuse of the existing number. We have not independently verified a current published processing time this session and are not quoting one — check the Board's own published guidance for the current turnaround before you plan a launch date around it.

What happens if you run without one

Advertising a medicine or a medicinal claim without Board approval is an offence under the Medicines (Advertisement and Sale) Act 1956. We are not quoting a penalty figure here — the schedule of penalties should be read from the current published text of the Act rather than from a marketing page. The practical exposure most clinics meet first is simpler and comes sooner: an enforcement query, a takedown, and a paid campaign switched off mid-flight.

What it means for your ad copy on Meta, Google, TikTok and XHS

Platform policy sits on top of the Act, never instead of it. Meta, Google and TikTok each run their own health-content rules that restrict outcome claims, before-and-after framing and prescription-product naming, and an ad can clear platform review while still being unapprovable under the Act — or be perfectly lawful and still be rejected by an automated reviewer. In practice the copy that survives both is the copy that carries no medicinal claim at all: credential-led, consultation-led, and factual about the premises. Where a medicinal claim is genuinely central to the campaign, the KKLIU approval has to come before the media plan, not after the ads are rejected.

shakalakaa advises clinic clients on KKLIU submission as part of campaign compliance work — scoping which pieces of copy fall inside the Act, preparing the Board application against the current Pharmaceutical Services Programme format, and sequencing the media plan around the approval window. This is a capability statement, not a turnaround or approval-rate claim. Talk to us if a campaign in scope needs a KKLIU number and you would rather have that handled inside the compliance workstream than raised as a blocker after the ads are rejected.

Does this apply to your clinic?

PHFSA's definition of a private healthcare facility or service is broad — it covers everything from private hospitals down to registered clinics, with the exact scope depending on the type and scale of the facility. If you're operating as a registered private healthcare facility of any size, facility-level advertising rules apply to you on top of whatever treatment-level rules govern your specialty (aesthetic, dental, or general practice).

Where this overlaps with our other compliance guides

Our MDC Ad Checker already screens for one facility-level issue specifically — advertising the practice premises itself without checking PHFSA presentation rules — as part of its 10-rule dental compliance check, and the underlying open rule set cites the PHFSA text directly for that rule. For the general KKM/MDC framework, our KKM Ad Checker screens aesthetic-clinic ad copy against the wider healthcare advertising ruleset — the natural conversion surface for this cluster. For aesthetic clinics, see our broader cosmetic clinic advertising compliance guide for the treatment-level rules that sit alongside this facility-level layer.

Not sure which layer
applies to your ads?

Run your dental or aesthetic clinic copy through the free checker that covers both treatment and facility-level rules.

Cite this

shakalakaa (Plixitt Solutions). “Advertising Guidelines for Healthcare Facilities & Services (Malaysia).”

https://shakalakaa.my/resources/advertising-guidelines-for-healthcare-facilities-and-services · Updated 2026-09-11

Licensed under CC BY 4.0.

FAQ

Frequently Asked
Questions.

They're a distinct layer of rules from treatment-level advertising restrictions — governing how the facility or premises itself (not a specific treatment) may be represented in advertising, under the Private Healthcare Facilities and Services Act 1998 (PHFSA), with the Ministry of Health's Medicine Advertisements Board issuing specific guidance on top of it.
Treatment-level rules restrict claims about a specific procedure — guarantees, before/after photos, pricing. Facility-level rules under PHFSA govern how the premises, registration status, location and services on offer are presented, independent of any specific treatment claim.
PHFSA's definition of a private healthcare facility or service covers a broad range of premises, from private hospitals down to registered clinics — the exact scope depends on the type and scale of the facility, so any clinic operating as a registered private healthcare facility falls within it.
KKLIU is the approval serial number issued by the Ministry of Health's Medicine Advertisements Board under the Medicines (Advertisement and Sale) Act 1956. The requirement attaches to the advertisement rather than to the clinic: copy that names a medicine or makes a medicinal claim needs Board approval before publication and must display the approved KKLIU number and its expiry. Factual practice advertising — registration, location, hours, qualifications, the consultation — generally does not.
Yes — shakalakaa advises clinic clients on KKLIU submission as part of campaign compliance work: scoping which pieces of copy fall inside the Medicines (Advertisement and Sale) Act 1956, preparing the Board application against the current Pharmaceutical Services Programme format, and sequencing the media plan around the approval window. This is a capability statement, not a turnaround or approval-rate claim. Book a strategy call to scope it against a specific campaign.

LET'S START
THE CONVO.